
This medication is compounded by a licensed 503A pharmacy in accordance with Section 503A of the Federal Food, Drug & Cosmetic Act, and may only be dispensed pursuant to a valid, patient-specific prescription issued by a licensed healthcare practitioner following an individualized medical evaluation. The FDA does not review or approve compounded medications, including compounded tirzepatide, for safety, effectiveness, or quality. Compounded tirzepatide has not been FDA-approved for weight loss or any other indication, though peer-reviewed and third-party research suggests potential clinical benefits. Individual results will vary. This compounded formulation is not affiliated with, endorsed by, reviewed by, or intended to replace any FDA-approved product manufactured by Eli Lilly and Company. EOS Health and its pharmacy partners have no affiliation with Eli Lilly and Company.
Compounded Tirzepatide provides dual-action benefits by mimicking GLP-1 and GIP hormones to regulate blood sugar, suppress appetite, and slow digestion.
Significant Weight Loss: Clinical studies have demonstrated an average body weight reduction of 15% to 22% when combined with lifestyle modifications.
Enhanced Appetite Suppression: The dual-receptor activation signals the brain to increase satiety, helping patients manage portion sizes naturally.
Delayed Gastric Emptying: It slows down the digestive process, prolonging feelings of fullness and minimizing cravings throughout the day.
Blood Sugar Control: By stimulating insulin secretion and reducing glucagon production, it stabilizes blood sugar levels and prevents post-meal energy crashes.
Metabolic Support: Many compounded formulas are paired with Vitamin B12 to boost energy levels, promoting better adherence to diet and exercise regimens.